COVID-19 vaccine trial begins in US | Daily News


 

COVID-19 vaccine trial begins in US

A clinical trial evaluating a vaccine designed to protect against the new Coronavirus will begin today, according to Government officials in the USA.

The first participant in the trial will receive the experimental vaccine. The National Institutes of Health is funding the trial,   which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle, officials said.

Public health officials say it will take a year to 18 months to fully validate any potential vaccine.

Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There is no chance participants could get infected from the shots, because they don’t contain the virus itself.

The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.

Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed.

The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. (Fox 10 News)

 


Visit Kapruka.com Sri Lanka's Largest online shop. Over 125,000 unique categories such as Fresh Flowers, Cakes, Food, Jewllery, Childrens Toys and other Sri Lankan e-commerce categories. Low delivery cost to most cities here and free delivery in Colombo.

Add new comment